Table 1.
Groups | PRRSV | dpc | Lung lesion score | ||
---|---|---|---|---|---|
Vaccination (28 days) |
Challenge (63 days) |
Macroscopic | Microscopic | ||
Vac1A/Ch1−2 | Porcilis PRRS | PRRSV−1 & −2 | 7 | 63.17±12.01a | 3.25±0.42a |
14 | 46.67±10.33a | 2.5±0.55a | |||
Vac1B/Ch1−2 | UNISTRAIN PRRS | PRRSV−1 & −2 | 7 | 64.17±10.21a | 3.33±0.52a |
14 | 48.33±9.83a | 2.67±0.82a | |||
Vac2A/Ch1−2 | Ingelvac PRRS MLV | PRRSV−1 & −2 | 7 | 32.5±7.58b | 2.42±0.49b |
14 | 23.33±15.38b | 1.42±0.49b | |||
Vac2B/Ch1−2 | Fostera PRRS | PRRSV−1 & −2 | 7 | 33.33±8.76b | 2.33±0.52b |
14 | 24.17±11.58b | 1.33±0.52b | |||
UnVac/Ch1−2 | None | PRRSV−1 & −2 | 7 | 63.33±10.33a | 3.83±0.41a |
14 | 53.33±10.33a | 3±0.63a | |||
UnVac/UnCh | None | None | 7 | 0.83±2.04c | 0.17±0.41c |
14 | 0c | 0.17±0.41c | |||
Different letters (a, b and c) at days post challenge indicate significant differences among groups.